Home LiteratureArticle Details
PMID: 7667317 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

Agarwal ML, Agarwal A, Taylor WR, Stark GR

Abstract

Increased expression of wild-type p53 in response to DNA damage arrests cells late in the G1 stage of the cell cycle by stimulating the synthesis of inhibitors of cyclin-dependent kinases, such as p21/WAF1. To study the effects of p53 without the complication of DNA damage, we used tetracycline to regulate its expression in MDAH041 human fibroblasts that lack endogenous p53. When p53 is expressed at a level comparable to that induced by DNA damage in other cells, most MDAH041 cells arrested in G1, but a significant fraction also arrested in G2/M. Cells released from a mimosine block early in S phase stopped predominantly in G2/M in the presence of p53, confirming that p53 can mediate arrest at this stage, as well as in G1. In these cells, there was appreciable induction of p21/WAF1. MDAH041 cells arrested by tetracycline-regulated p53 for as long as 20 days resumed growth when the p53 level was lowered, in striking contrast to the irreversible arrest mediated by DNA damage. Therefore, irreversible arrest must involve processes other than or in addition to the interaction of p53-induced p21/WAF1 with G1 and G2 cyclin-dependent kinases.

Related Genes
p53
MeSH Terms
Cell Cycle/genetics Cell Division/genetics Cell Line Cyclin-Dependent Kinase Inhibitor p21 Cyclins/metabolism Fibroblasts/cytology,metabolism Gene Expression Regulation Genes, p53 Humans
Chemicals
CDKN1A protein, human Cyclin-Dependent Kinase Inhibitor p21 Cyclins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Agarwal M L
Department of Molecular Biology, Cleveland Clinic Foundation, OH 44195, USA.
Agarwal A
Taylor W R
Stark G R
References (29)
29 references, click to expand
  1. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.
    Cell. 1990 Aug 24;62(4):671-80 PMID: 2143698
  2. Universal control mechanism regulating onset of M-phase.
    Nature. 1990 Apr 5;344(6266):503-8 PMID: 2138713
  3. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
    Genes Dev. 1991 Feb;5(2):151-9 PMID: 1995413
  4. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
  5. Participation of p53 protein in the cellular response to DNA damage.
    Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 PMID: 1933891
  6. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
    Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5547-51 PMID: 1319065
  7. Cancer. p53, guardian of the genome.
    Nature. 1992 Jul 2;358(6381):15-6 PMID: 1614522
  8. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.
    Cell. 1992 Sep 18;70(6):923-35 PMID: 1356076
  9. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.
    Cell. 1992 Sep 18;70(6):937-48 PMID: 1525830
  10. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.
    Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9210-4 PMID: 1409626
  11. p53 is required for radiation-induced apoptosis in mouse thymocytes.
    Nature. 1993 Apr 29;362(6423):847-9 PMID: 8479522
  12. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage.
    Cancer Res. 1993 Sep 15;53(18):4164-8 PMID: 8364909
  13. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.
    Cell. 1993 Sep 24;74(6):957-67 PMID: 8402885
  14. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  15. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  16. p21 is a universal inhibitor of cyclin kinases.
    Nature. 1993 Dec 16;366(6456):701-4 PMID: 8259214
  17. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    Cancer Res. 1994 Mar 1;54(5):1169-74 PMID: 8118801
  18. Sequence-specific transcriptional activation is essential for growth suppression by p53.
    Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):1998-2002 PMID: 8134338
  19. Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53.
    Nucleic Acids Res. 1994 Mar 25;22(6):1012-7 PMID: 8152906
  20. Induction of WAF1/CIP1 by a p53-independent pathway.
    Cancer Res. 1994 Jul 1;54(13):3391-5 PMID: 8012956
  21. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
    Cancer Res. 1994 Sep 15;54(18):4855-78 PMID: 8069852
  22. Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard.
    Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9480-4 PMID: 7937793
  23. Cell cycle regulation of gene amplification.
    Cold Spring Harb Symp Quant Biol. 1993;58:655-67 PMID: 7956082
  24. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.
    Genes Dev. 1994 Nov 1;8(21):2540-51 PMID: 7958916
  25. Evidence for a second cell cycle block at G2/M by p53.
    Oncogene. 1995 Jan 5;10(1):109-15 PMID: 7529916
  26. The p53-mediated G1 checkpoint is retained in tumorigenic rat embryo fibroblast clones transformed by the human papillomavirus type 16 E7 gene and EJ-ras.
    Mol Cell Biol. 1995 Mar;15(3):1446-54 PMID: 7862138
  27. Normal cytotoxic response of skin fibroblasts from patients with Li-Fraumeni familial cancer syndrome to DNA-damaging agents in vitro.
    Cancer Res. 1987 Aug 1;47(15):4229-34 PMID: 3111682
  28. A reversible arrest point in the late G1 phase of the mammalian cell cycle.
    Exp Cell Res. 1990 Feb;186(2):332-9 PMID: 2153561
  29. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization.
    Cancer Res. 1990 Dec 15;50(24):7979-84 PMID: 2253239
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1995-08-29
Pages
8493-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC41183
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com